Target Trial Emulation to Improve Causal Inference from Observational Data: What, Why, and How?
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Target trial emulation has drastically improved the quality of observational studies investigating the effects of interventions. Its ability to prevent avoidable biases that have plagued many observational analyses has contributed to its recent popularity. This review explains what target trial emulation is, why it should be the standard approach for causal observational studies that investigate interventions, and how to do a target trial emulation analysis. We discuss the merits of target trial emulation compared with often used, but biased analyses, as well as potential caveats, and provide clinicians and researchers with the tools to better interpret results from observational studies investigating the effects of interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397 · cited 1×
“34 – 37 For instance, randomized trials have examined the effects of targeting a certain hemoglobin level through erythropoietin use in patients with anemia and CKD. 34 This can be emulated in an observational target trial emulation analysis.”
Marginal Structural Models and Causal Inference in Epidemiology
Robins, J. M., Hernán, M. Á., & Brumback, B. (2000) · Epidemiology · doi:10.1097/00001648-200009000-00011 · Cited by 5,581
Correction of anemia with epoetin alfa in chronic kidney disease
Singh, A. K., Szczech, L., Tang, K. L., Barnhart, H., Sapp, S., Wolfson, M., & Reddan, D. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa065485 · Cited by 2,762
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
Dagan, N., Barda, N., Kepten, E., Miron, O., Perchik, S., Katz, M. A., Hernán, M. A., Lipsitch, M., Reis, B., & Balicer, R. D. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2101765 · Cited by 2,527 · cited 1×
“Furthermore, the target trial framework can be applied to every causal question on interventions, including surgeries, 18 vaccinations, 19 medications, 20 and lifestyle (diet and physical activity).”
Negative Controls: A Tool for Detecting Confounding and Bias in Observational Studies
Lipsitch, M., Tchetgen Tchetgen, E., & Cohen, T. (2010) · Epidemiology · doi:10.1097/ede.0b013e3181d61eeb · Cited by 1,583 · cited 1×
“68,69 These are outcomes for which treatment is not expected to have any effect.”
Hernán, M. A., Sauer, B. C., Hernández-Díaz, S., Platt, R., & Shrier, I. (2016) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2016.04.014 · Cited by 1,097 · cited 2×
“2 These designs introduce avoidable biases on top of confounding, such as immortal time bias, lead time bias, or selection bias.”
Lund, J. L., Richardson, D. B., & Stürmer, T. (2015) · Current Epidemiology Reports · doi:10.1007/s40471-015-0053-5 · Cited by 739 · cited 2×
“54 Some data sources may be more suitable to investigate the effects of treatments than others because they include more detailed confounder information, such as laboratory data or test results.”
Observational research, randomised trials, and two views of medical science
Vandenbroucke, J. P. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050067 · Cited by 416
Does obesity shorten life? The importance of well-defined interventions to answer causal questions
Hernán, M. A., & Taubman, S. L. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.82 · Cited by 384 · cited 1×
“33 The same reasoning applies to other biomarkers, such as blood pressure (antihypertensive agents), LDL cholesterol (statins and ezetimibe), and serum phosphate levels (phosphate binders).”
Swanson, S. A., Tiemeier, H., Ikram, M. A., & Hernán, M. A. (2017) · Epidemiology · doi:10.1097/ede.0000000000000699 · Cited by 202 · cited 1×
“25 Note that the framework has focused on emulating parallel group trials.”
Cited by
Fu, E. L., Harhay, M. O., Schneeweiss, S., Desai, R. J., & Hernán, M. A. (2026) · BMJ · doi:10.1136/bmj-2025-084909 · Cited by 42
Self-citationHattori, K., Sakaguchi, Y., Oka, T., Asahina, Y., Kawaoka, T., Doi, Y., Hashimoto, N., Kusunoki, Y., Yamamoto, S., Yamato, M., et al. (2024) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000000000000425 · Cited by 27
Metadata
- Authors
- Fu, E. L.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2023-05-03
- Volume
- 34
- Issue
- 8
- Pages
- 1305-1314
- ISSN
- 1046-6673 (ISSN-L)
- 1533-3450
- OpenAlex
- W4367833841
- Cited by
- 184
- References
- 10
- FWCI
- 36.32
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Target Trial Emulation to Improve Causal Inference from Observational Data: What, Why, and How? https://app.cochat.ai/papers/10.1681/asn.0000000000000152
- The paper
- Fu, E. L. (2023). Target Trial Emulation to Improve Causal Inference from Observational Data: What, Why, and How? Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.0000000000000152
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.